MedPath

Evaluating Outcomes in the Placement of Boomerang Percutaneous Device

Terminated
Conditions
Medical Device
Angiography
Interventions
Device: Boomerang closure device
Registration Number
NCT00732628
Lead Sponsor
University of Michigan
Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of the Boomerang percutaneous closure device following diagnostic cerebral angiography or neurointerventional procedures.

Background:

Very few publications have evaluated this relatively novel percutaneous closure device.

Detailed Description

The purpose of this study is to document our experiences using the Boomerang closure device. Several different closure devices are used in the department of Radiology. A closure device is something that is placed in the artery in the leg just prior to removing the catheters from your leg at the end of the imaging or treatment procedure that is to be performed in the Department of Radiology. The devices used are all FDA approved. This study will compare the Boomerang device (a newer FDA approved device) to the other older devices currently being used. You may not have the Boomerang device used in your procedure; however, the Boomerang device is used in almost all of our patients undergoing a neuro imaging or treatment procedure. The neuroradiologist will determine which device if any is best for you based on the size of your artery, your medical condition etc. We will only collect data about you and your procedure if the Boomerang device is used.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Any patient that has a percutaneous Boomerang closure device placed after having a neuro-intervention
Exclusion Criteria
  • Patients that do not have this medical device used post procedure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Boomerang percutaneous closure unitBoomerang closure devicepatients having a Boomerang percutaneous closure device after a Neurointerventional study
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath